- Home
- GORO vs IKT Comparison
GORO vs IKT Comparison
Compare GORO & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GORO
- IKT
- Stock Information
- Founded
- GORO 1998
- IKT 2008
- Country
- GORO United States
- IKT United States
- Employees
- GORO N/A
- IKT N/A
- Industry
- GORO Precious Metals
- IKT Biotechnology: Pharmaceutical Preparations
- Sector
- GORO Basic Materials
- IKT Health Care
- Exchange
- GORO Nasdaq
- IKT Nasdaq
- Market Cap
- GORO 133.7M
- IKT 123.7M
- IPO Year
- GORO N/A
- IKT 2020
- Fundamental
- Price
- GORO $0.82
- IKT $1.62
- Analyst Decision
- GORO Strong Buy
- IKT Buy
- Analyst Count
- GORO 2
- IKT 2
- Target Price
- GORO $1.38
- IKT $8.00
- AVG Volume (30 Days)
- GORO 2.3M
- IKT 135.2K
- Earning Date
- GORO 11-04-2025
- IKT 11-13-2025
- Dividend Yield
- GORO N/A
- IKT N/A
- EPS Growth
- GORO N/A
- IKT N/A
- EPS
- GORO N/A
- IKT N/A
- Revenue
- GORO $49,824,000.00
- IKT N/A
- Revenue This Year
- GORO N/A
- IKT N/A
- Revenue Next Year
- GORO $117.97
- IKT N/A
- P/E Ratio
- GORO N/A
- IKT N/A
- Revenue Growth
- GORO N/A
- IKT N/A
- 52 Week Low
- GORO $0.12
- IKT $1.15
- 52 Week High
- GORO $0.93
- IKT $4.20
- Technical
- Relative Strength Index (RSI)
- GORO 58.37
- IKT 48.62
- Support Level
- GORO $0.77
- IKT $1.57
- Resistance Level
- GORO $0.93
- IKT $1.70
- Average True Range (ATR)
- GORO 0.07
- IKT 0.12
- MACD
- GORO -0.01
- IKT 0.01
- Stochastic Oscillator
- GORO 47.73
- IKT 48.39
About GORO Gold Resource Corporation
Gold Resource Corp is a producer of metal concentrates that contain gold, silver, copper, lead, and zinc in Oaxaca, Mexico. . It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America. The Company has two reporting segments, based on geographic regions. Oaxaca, Mexico represents the Company's only operating segment with a production stage property. The Company's other reporting segment is Michigan, U.S.A., with an exploration stage property.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.